AcuityMD, the AI platform for MedTech, has raised $80.0 million in new funding. This significant investment round highlights the company's growing influence and underscores its position as a key technology provider for the medical technology industry. AcuityMD is currently trusted by more than 400 MedTech companies, including eight of the top 10, leveraging artificial intelligence to enhance commercial strategies and drive market penetration.
The company's platform combines real-world healthcare data with AI-powered insights to assist commercial leaders. It enables MedTech companies, from pre-commercial startups to large enterprises, to identify target markets, surface top opportunities, and accelerate business growth. By streamlining the sales process, AcuityMD aims to speed up the adoption of critical medical technologies. Its impact and potential were recently recognized when it was named to Forbes' 2025 "Next Billion-Dollar Startups" list, an elite group of 25 venture-backed U.S. companies identified as most likely to reach a $1 billion valuation.
The newly secured capital will be strategically deployed to further develop AcuityMD's platform capabilities, expand its market reach, and scale its operations to meet increasing demand within the MedTech sector. This funding is expected to support the company's strategic growth initiatives, allowing it to continue innovating and providing essential tools that empower medical technology companies to sell faster and more effectively. AcuityMD plans to build on its current momentum, aiming to further solidify its role in accelerating the commercial success and widespread adoption of medical innovations globally.
